SOX2 and ovarian carcinoma: The knockdown of the CD90 molecule in A2780 (ovarian cancer) cells decreased the proliferative activity of cells, relative cell growth (self-renewal potential), and expression of the pluripotency-related markers Nanog and Sox2.